Published: Fri, November 03, 2017
Finance | By Claude Patterson

Most Active mover Update on Allergan plc (NYSE:AGN)

Most Active mover Update on Allergan plc (NYSE:AGN)

Covering sell-side analysts have recently weighed in on shares of Allergan plc (NYSE:AGN). Royal Bank Of Canada dropped their target price on Allergan PLC. from $250.00 to $221.00 and set an "outperform" rating for the company in a research report on Thursday. For the quarter, shares have been noted at -26.27%. Wells Fargo & Company increased their price target on shares of Allergan $278.00 and gave the company an "outperform" rating in a research report on Thursday, August 3rd. Allergan plc (NYSE:AGN) has a 20-Day average volume of 5.07 Million. Cowen and Company set a $280.00 target price on Allergan PLC. and gave the company a "buy" rating in a research note on Friday, October 20th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have given a buy rating to the stock. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.

Allergan PLC had a net margin of 28.06% and a return on equity of 7.67%. Gemmer Asset Ltd has invested 0.01% in Allergan plc Ordinary Shares (NYSE:AGN).

As a result, the company reported a net loss of $4.03 billion or $12.07 per share, compared with a profit of $15.15 billion or $38.58 per share a year earlier.

Analysts believe that the company has the potential to earn average revenue of $4.03 Billion for the current quarter. Allergan PLC. The company's revenue was up 11.4% on a year-over-year basis. During the same period a year ago, the firm posted $3.32 earnings per share.

The stock of Allergan plc Ordinary Shares (NYSE:AGN) is a huge mover today! This repurchase authorization authorizes the company to repurchase up to 2.8% of its shares through open market purchases. Currently, Allergan plc (NYSE:AGN) has an average volume of 3.14 Million. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & global copyright and trademark laws. The correct version of this report can be accessed at

A number of large investors have recently bought and sold shares of the business. Toth Fin Advisory Corp reported 0.06% of its portfolio in Allergan plc Ordinary Shares (NYSE:AGN). Northern Trust Corp now owns 4,492,944 shares of the company's stock valued at $1,092,189,000 after purchasing an additional 364,722 shares in the last quarter. Hanlon Investment Management Inc. purchased a new stake in Allergan the first quarter valued at approximately $2,314,000. Integrated Investment Consultants LLC raised its position in Allergan PLC by 35.2% in the second quarter. The institutional investor owned 21,390 shares of the company's stock after acquiring an additional 2,368 shares during the quarter. Finally, High Point Bank & Trust Co. raised its position in Allergan PLC by 19.9% in the second quarter. Integrated Investment Consultants LLC now owns 592 shares of the company's stock valued at $137,000 after buying an additional 154 shares during the period. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders.

Among 25 analysts covering Allergan Inc. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products.

Like this: